hepatitis-c

Documents about hepatitis-c

• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection#969271ClinicalTrials.gov
• Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.#992373ClinicalTrials.gov
• Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)#307350ClinicalTrials.gov
• VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers#827615ClinicalTrials.gov
• Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon#841127ClinicalTrials.gov
• The three-decade trajectory of hepatitis C burden among women of reproductive age in China: a retrospective and predictive study.#223074NCBI PubMed Central
• Expanded Access to Glecaprevir/ Pibrentasvir#826116ClinicalTrials.gov
• Computer-based Intervention for Alcohol-using HIV/HCV+ Women#836037ClinicalTrials.gov
• Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes#847052ClinicalTrials.gov
• "Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"#872921ClinicalTrials.gov
• Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease#903184ClinicalTrials.gov
• A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat#994097ClinicalTrials.gov
• Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection#1033087ClinicalTrials.gov
• NanoVirDetect - Nanostrukturiertes Elektrodensystem zur Detektion von Viren und Bakterien, Teilvorhaben: Herstellung des Mikrofluidiksystems mit integrierten Nanoelektrodenarrays : Schlußbericht ; Laufzeit des Vorhabens/Berichtszeitraum: 1.4.2001 - 31.3.2004#129757DataCite
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures#1033025ClinicalTrials.gov
• Phenotypic analysis of mutations at residue 146 provides insights into the relationship between NS5A hyperphosphorylation and hepatitis C virus genome replication#190298Ora Oxford University Research
• Impact of Antiviral Therapy Scale-Up Among People Who Inject Drugs in Scotland: Regional Evidence of Hepatitis C Virus Elimination.#319229NCBI PubMed Central
• HCV Self-testing in Malaysia#852423ClinicalTrials.gov
• Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment#856959ClinicalTrials.gov
• Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy#867279ClinicalTrials.gov
• High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV#877788ClinicalTrials.gov
• Evaluation of HepCure Toolkit to Improve Harvoni Adherence#898179ClinicalTrials.gov
• European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol#904752ClinicalTrials.gov
• A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects#905184ClinicalTrials.gov
• 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis#914385ClinicalTrials.gov
• ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing#1010606ClinicalTrials.gov
• Integration of HIV, Hepatitis B, and C, and sexually transmitted infections services: A scoping review of the benefits and challenges.#162169NCBI PubMed Central
• Physician perspectives on hepatitis c treatment during pregnancy: a multinational multispecialty survey#305633Recep Tayyip Erdoğan University Institutional Repository
• Variations in the viral hepatitis C prevalence and treatment status by material hardship and cumulative risk among people who inject drugs.#615920NCBI PubMed Central
• Are there any non-invasive methods to predict liver fibrosis in children infected by hepatitis C virus rather than liver biopsy?#685550NCBI PubMed Central
• Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients#848092ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients#856647ClinicalTrials.gov
• Interferon α 2b Pharmacovigilance Study#862075ClinicalTrials.gov
• A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects#872473ClinicalTrials.gov
• A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation#907925ClinicalTrials.gov
• Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation.#1365NCBI PubMed Central
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#149912Unpaywall
• Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis#833652ClinicalTrials.gov
• Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease#843227ClinicalTrials.gov
• Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.#846563ClinicalTrials.gov
• Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)#846947ClinicalTrials.gov
• DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs#855440ClinicalTrials.gov
• Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection#863329ClinicalTrials.gov
• Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment#881570ClinicalTrials.gov
• Intervention to Reduce Injection Drug Use#893999ClinicalTrials.gov
• Evaluation of Dried Blood Spot for HCV RNA Testing#1031197ClinicalTrials.gov
• Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m#847212ClinicalTrials.gov
• Frequent Longitudinal Sampling of Hepatitis C Virus Infection in Injection Drug Users Reveals Intermittently Detectable Viremia and Reinfection#642252eScholarship
• WHO technical report on monitoring timepoints in adult patients treated for HCV with pegylated interferon alpha and ribavirin#627345WHO IRIS
• PICO 1: testing: a systematic review and meta-analysis of targeted HCV antibody testing interventions#627347WHO IRIS